745 - Amryt Pharma #AMYT & Falanx Group #FLX
On Today’s Vox Markets podcast: 28th March 2017
Mark Sumeray, Chief Medical Officer of Amryt Pharma #AMYT discusses the commencement of "EASE", its Phase 3 clinical trial of AP101, Amryt's lead drug candidate. (Interview starts at 1 minutes 23 seconds)
Jay Abbott, Managing Director of Falanx Cyber Defence #FLX explains the launch of MidGARD, its wholly owned, proprietary, cyber threat detection platform. (Interview starts at 13 minutes 33 seconds)
Today's suggested, "One for your Watchlist", is: Frontera Resources #FRR Submitted by: Duncan (Feature starts at 22 minutes 20 seconds)
Plus the Top 5 Most Followed Companies on Vox Markets in the Last 24 Hours & The Top 5 Most Liked RNS's on the Vox Markets website this morning.
Vox Markets is a stock market resource platform that aggregates investor relations information.
It specialises in the latest stock market news, company information, live prices, interviews and views from Asset Managers, Stock Brokers, Hedge Fund Managers, Private Investors, Independent Financial Advisors and Investment Managers.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business